“genentech” Archives

in
Entry Author Date Location
Alector Raises $32M For Immune-Based Neuro Drug Development 09/16/15 San Francisco
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
West Coast Biotech Roundup: Tandem, Pathway Genomics, Denali & More 09/10/15 San Diego
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer 08/31/15 New York
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal 08/24/15 Boston
Versant Walks Biotech “High Line” With a New Manhattan Incubator 08/24/15 New York
West Coast Biotech Roundup: Global Blood, Invitae, GeneWEAVE, Adynxx 08/13/15 San Francisco
Clinical Trial Innovation Prize Backs Ideas Using Health Records, Apps 08/11/15 Wisconsin
Data Gatherer Turned Drug Developer 23andMe Raises $79.1M, Wants More 07/06/15 San Francisco
ONL Therapeutics Promotes New Lead Drug, Expands Clinical Program 07/06/15 Detroit Ann Arbor
Houston Dares to Challenge the Bicoastal Model of Biotech Growth 06/23/15 Texas
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
West Coast Biotech Roundup: PCSK9, Amgen, SeaGen, Twist, Serenus 06/11/15 Seattle
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
At Exelixis, Morrissey Dreams Of Getting the Band Back Together 06/01/15 San Francisco
Denali Rises With $217M and Genentech Alumni to Fight Brain Diseases 05/14/15 San Francisco
Moderna’s Third mRNA Startup, Elpidera, Sets Sights on Rare Diseases 05/12/15 Boston
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Cancer Groups Tap The Crowd To Boost Clinical Trial Participation 04/01/15 Wisconsin
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitions 03/12/15 San Francisco
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Yes to Flexus: The Science And Strategy Behind A Huge Biotech Return 02/26/15 San Francisco
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Seragon CEO Rich Heyman Is Going on Hiatus 02/20/15 San Diego
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
FDA’s Hamburg Stepping Down With Biopharma Turnaround as Her Legacy 02/05/15 National
Page 2 of 18 « previous page · next page »